United States. Contract blending and tolling
Toll manufacturing and chemical blending companies in the USA
Tolling and contract manufacturing get used interchangeably and are not the same arrangement. Under a true toll, you own the materials throughout and pay for processing; under contract manufacturing the blender buys the inputs and sells you the finished product. That distinction decides who holds the inventory, who carries the regulatory obligations and who is exposed when a raw material price moves. This page sets out the difference and what to qualify before you send a formulation to anyone.
Who owns the material
the question that separates tolling from contract manufacturing, and it changes everything downstream
TSCA
chemical substances in US commerce sit under an EPA inventory regime
Formulation, not recipe
what you disclose and what you protect are negotiated before, never after
| Option | ||||||
|---|---|---|---|---|---|---|
| True toll blending Established products where you control procurement | You supply the raw materials and the blender processes them for a fee. They never take title to your inputs. | You do, throughout. That is the defining feature and it drives everything else. | Largely you, as the party placing the substance in commerce, though the site carries its own obligations for handling and storage. Which regimes apply depends on the substance and its use. | You are, entirely. If a raw material doubles you absorb it, and if it halves you keep the benefit. | You disclose the formulation to the blender under agreement. Negotiate what they may retain and what they may not make for others before disclosure. | What are your yield and loss allowances, and who bears material lost in changeover? |
| Contract manufacturing Buyers who want one price and no procurement | The manufacturer buys the inputs and sells you finished product at a price per unit. | They do, until the finished goods are delivered. | More sits with them as manufacturer, though obligations attaching to the party marketing the product remain yours. | They are, in the short run, and you are over time through price reviews. Ask how and when prices are reset. | Same disclosure question, with more risk that process improvements they develop are treated as theirs. | How often are prices reviewed, against what index, and with what notice? |
| Private label from an existing formula Speed to market without a formulation | You buy the manufacturer's existing product under your own brand. | They do, including the formulation. | Shared, and it depends on the product category. Labelling and marketing obligations generally sit with the brand owner. | They are, and your leverage is limited by having no alternative source for that exact product. | There is no formulation of yours to protect, and equally nothing stopping them supplying a competitor the same product. | Is this formulation exclusive to me, and if not, in what markets do you supply it to others? |
| Your own plant High volume and formulations central to the business | You build or buy the blending capability yourself. | You do, everything, including the permits and the liabilities. | All of it, including site permitting, handling, storage and waste. This is a substantial undertaking rather than a procurement decision. | You are, with the full benefit of scale when you have it. | Fully retained, which for some businesses is the entire argument. | Not applicable; the question becomes what permitting and compliance capability you need to hire. |
How this compares, and what it will not do
This compares the ARRANGEMENTS rather than naming blenders, because the arrangement decides ownership, regulatory responsibility and price exposure, and those are what people get wrong. A list of company names would not.
Order runs from the arrangement where you retain most control and obligation to the one where you retain least, which is also roughly the order of margin you keep.
Regulatory statements point at the EPA and FDA's own pages. Which regime applies to a specific product is a question for a regulatory professional and depends on the substance and its use.
We blend nothing and recommend no company. Tell us the chemistry and volume and blenders will quote you directly.
- True toll blending EPA, TSCA Chemical Substance Inventory
- Contract manufacturing EPA, TSCA Chemical Substance Inventory
- Private label from an existing formula FDA, guidance and regulation for food and dietary supplements
- Your own plant EPA, TSCA Chemical Substance Inventory
Toll Blenders is an independent site operated by Ellul Solutions Ltd. It is not affiliated with, endorsed by or connected to any agency or company named here, and nothing on it is legal, customs, regulatory or trade advice. We take no commission and carry no paid placements. No prices are published on this site because blending is quoted per formulation, batch size and vessel. Which regulatory regimes apply to a product, and who carries which obligation, depends on the substance, its use and the arrangement, and is a question for a regulatory professional rather than for this page. Regulatory positions are summarised from the agencies' own pages on the date shown and are a starting point for your own enquiries, not a substitute for them.
Want quotes from suppliers that fit?
Tell us the chemistry, the batch size and the annual volume. US toll blenders and contract manufacturers will contact you directly.
Tolling against contract manufacturing: what changes with ownership, 2026
Last updated
The two arrangements are described interchangeably in the market and differ in every respect that matters. This table sets the consequences side by side so a quotation can be read for what it actually proposes.
This table describes the commercial and regulatory structure of tolling and contract manufacturing arrangements. It quotes no prices, because blending is quoted per formulation, per batch size and per vessel, and no published figure would be meaningful. Regulatory statements point at the EPA's TSCA Chemical Substance Inventory and at FDA guidance for food and dietary supplements as starting points; which regime applies to a given product, and who carries which obligation, depends on the substance, its use and the arrangement, and is a question for a regulatory professional. Nothing here is legal or regulatory advice.
| Aspect | Under a true toll | Under contract manufacturing | What to settle in the agreement |
|---|---|---|---|
| Material ownership | Yours throughout | Theirs until delivery | When title passes, and who insures material on their site |
| Input price risk | Yours entirely | Theirs short term, yours through reviews | The price review mechanism, index and notice period |
| Yield and loss | Yours, on their process | Built into their price | Yield allowance, and who bears changeover losses |
| Inventory financing | You fund the raw materials | They fund them | Payment terms against production schedule |
| Formulation | Yours, disclosed to them | Yours or theirs, depending | Non-use, non-compete scope and what survives termination |
| Process improvements | Ambiguous unless stated | Often claimed by the manufacturer | Who owns improvements developed during the work |
| Regulatory obligations | Largely yours, plus their site duties | More sits with them | Which regimes apply and who files what |
| Exit | Take materials and go, in principle | Requalify a new supplier from scratch | Notice, transfer of specifications and any tooling |
- Under a true toll the customer owns the raw materials throughout and pays for processing, which is what distinguishes it from contract manufacturing.
- Ownership determines who carries input price risk, who finances inventory and who bears yield loss.
- Chemical substances in US commerce sit under an EPA inventory regime, and which obligations attach depends on the substance and its use.
- Process improvements developed during a tolling relationship are frequently ambiguous unless the agreement says who owns them.
- Exit is materially easier from a toll than from contract manufacturing, where a new supplier must be requalified from the beginning.
Cite this page
“Tolling against contract manufacturing: what changes with ownership, 2026”, Toll Blenders, https://tollblenders.com/ (updated 2026-08-15). This table describes the commercial and regulatory structure of tolling and contract manufacturing arrangements. It quotes no prices, because blending is quoted per formulation, per batch size and per vessel, and no published figure would be meaningful. Regulatory statements point at the EPA's TSCA Chemical Substance Inventory and at FDA guidance for food and dietary supplements as starting points; which regime applies to a given product, and who carries which obligation, depends on the substance, its use and the arrangement, and is a question for a regulatory professional. Nothing here is legal or regulatory advice.
The detail
Each one cites where its numbers come from.
Frequently asked
What is the difference between toll blending and contract manufacturing?
Ownership of the materials. Under a true toll you supply the raw materials and pay the blender a fee to process them, and they never take title. Under contract manufacturing they buy the inputs and sell you finished product. That single difference determines who carries input price risk, who finances inventory, who bears yield loss and how easily you can move the work elsewhere.
Which arrangement is better?
Neither, and it depends on your procurement capability. A toll suits a buyer who can buy inputs well and wants the benefit when prices fall, and who may want to move the work later. Contract manufacturing suits a buyer who wants one price per unit and no exposure to a raw materials market they do not follow. What matters is establishing which one a quotation actually proposes, because the two are used interchangeably in enquiries.
What is a yield allowance and why does it matter?
Blending loses material to changeovers, vessel heels and testing. Under a toll that loss is yours, incurred on somebody else's process, so the allowance assumed in the agreement is one of its most important numbers. Ask what allowance applies and who bears loss beyond it. A vague answer is expensive at volume and impossible to renegotiate once running.
How do I protect my formulation?
Settle confidentiality, non-use and the scope of any non-compete before you disclose, because afterwards you have no leverage. Non-use is the clause most often missing: confidentiality stops a blender telling people, non-use stops them using it. Also settle who owns process improvements developed during the work, which is ambiguous by default and which manufacturers commonly assume they own.
What should I check about a blender's equipment?
Vessel sizes with working volumes, matched against your batch size now and in two years, because a plant whose smallest vessel is far larger than your batch will price the inefficiency into your quote. Then changeover practice: what runs before and after your product, what the cleaning validation looks like, and how changeover loss is calculated. For contamination-sensitive products that is the decisive question.
Who carries the regulatory obligations?
It depends on the arrangement, the substance and its use. Chemical substances in US commerce sit under an EPA inventory regime and food and supplement products under FDA guidance. Broadly, more sits with the manufacturer under contract manufacturing and more with you under a toll, while the site always carries its own handling and storage duties. Which regimes apply to your product is a question for a regulatory professional rather than for a blender's sales team.
How hard is it to move to another blender?
Much easier from a toll than from contract manufacturing. Under a toll you own the materials and the specification and can in principle take both elsewhere. Under contract manufacturing you are requalifying a product from the beginning with a new supplier, including new testing and new stability data where relevant. If you expect to move the work, that difference should influence which arrangement you choose at the outset.
Sources
Establish the arrangement first
Who owns the materials, who carries the price risk, and the clauses to settle before a formulation leaves your building.